IHT Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,435
Closed -$207K – 1137
2024
Q4
$207K Sell
1,435
-1,331
-48% -$191K 0.01% 1013
2024
Q3
$407K Buy
+2,766
New +$397K 0.01% 786
2024
Q2
– Sell
-1,421
Closed -$261K – 1071
2024
Q1
$261K Buy
1,421
+4
+0.3% +$762 0.01% 845
2023
Q4
$255K Sell
1,417
-1
-0.1% -$156 0.01% 828
2023
Q3
$225K Sell
1,418
-58
-4% -$9.48K 0.01% 837
2023
Q2
$209K Sell
1,476
-65
-4% -$10.4K 0.01% 865
2023
Q1
$259K Sell
1,541
-1
-0.1% -$178 0.01% 751
2022
Q4
$261K Buy
1,542
+2
+0.1% +$363 0.02% 707
2022
Q3
$288K Buy
+1,540
New +$325K 0.02% 640
2021
Q2
– Sell
-1,127
Closed -$219K – 976
2021
Q1
$219K Buy
+1,127
New +$231K 0.02% 738

Other funds holding RGEN

IHT Wealth Management's RGEN Position: Q1 2025 in Review

IHT Wealth Management sold out of Repligen (RGEN) in Q1 2025, closing a stake of 1,435 shares — an estimated $207K sold.

IHT Wealth Management first reported a position in RGEN in Q1 2021 and held it in 10 quarters. The position peaked at $407K in Q3 2024. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • IHT Wealth Management reported no remaining Repligen position as of Q1 2025 after selling out during the quarter.
  • IHT Wealth Management sold 1,435 Repligen shares in Q1 2025, an estimated $207K.
  • IHT Wealth Management first reported a position in Repligen in Q1 2021 and held it in 10 quarters.
  • IHT Wealth Management's Repligen position peaked at $407K in Q3 2024.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on IHT Wealth Management's 13F filing for Q1 2025, filed 15 May 2025.